MindImmune

Developer of antibody-based drugs and therapeutics designed to treat diseases of the central nervous system. The company specializes in helping to recognize the therapeutic enhancements in targeting t...

Healthcare

Kingston, RI, United States

Founded 2016

10 employees

Website

Valuation

$43.5M

Market implied

Share Price

N/A

Total Raised

$30.3M

Last Round

N/A

Investors

+8 other investors

View all 8 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock MindImmune's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required